Odyssey Health (ODYY) Total Debt Growth (3y) (2017 - 2026)
Odyssey Health (ODYY) Total Debt Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.38 Bn | 176.08 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 129.56 Bn | 126.68 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 109.00 Bn | 99.78 Bn | 6.41 Bn | 4.70% |
| 4 | Boston Scientific | 68.59 Bn | 67.13 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 47.58 Bn | 43.90 Bn | 1.29 Bn | 0.11% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 28.55 Bn | 26.27 Bn | 1.98 Bn | -0.32% |
| 8 | Smith & Nephew | 27.05 Bn | 26.48 Bn | - | 5.42% |
| 9 | Koninklijke Philips | 25.59 Bn | 22.46 Bn | 2.07 Bn | 2.61% |
| 10 | Odyssey Health | 1.08 Mn | 782,508.17 | - | -13.80% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | -13.80% |
| Jan 31, 2026 | 23.41% |
| Oct 31, 2025 | 4.06% |
| Jul 31, 2025 | 9.01% |
| Apr 30, 2025 | 34.52% |
| Jan 31, 2025 | 38.84% |
| Oct 31, 2024 | 50.94% |
| Jul 31, 2024 | 21.01% |
| Apr 30, 2024 | 67.66% |
| Jan 31, 2024 | 94.36% |
| Oct 31, 2023 | 154.46% |
| Jul 31, 2023 | 157.20% |
| Apr 30, 2023 | 52.61% |
| Jan 31, 2023 | 59.34% |
| Oct 31, 2022 | 53.48% |
| Jul 31, 2022 | 56.12% |
| Apr 30, 2022 | 30.45% |
| Jan 31, 2022 | 29.14% |
| Oct 31, 2021 | 18.38% |
| Jul 31, 2021 | 42.39% |